О. В. Головенко
A5029660671- Inflammatory Bowel Disease
- Microscopic Colitis
- Gastrointestinal motility and disorders
- Eosinophilic Esophagitis
- Diverticular Disease and Complications
- Intestinal and Peritoneal Adhesions
- Autoimmune and Inflammatory Disorders
- Rheumatoid Arthritis Research and Therapies
- Gastric Cancer Management and Outcomes
- Diet and metabolism studies
- Delphi Technique in Research
- Helicobacter pylori-related gastroenterology studies
- Clostridium difficile and Clostridium perfringens research
- Digestive system and related health
- Biomedical and Chemical Research
- Myofascial pain diagnosis and treatment
- Hidradenitis Suppurativa and Treatments
- Therapeutic Uses of Natural Elements
- Pharmacological Effects of Natural Compounds
- Melanoma and MAPK Pathways
- Cardiac, Anesthesia and Surgical Outcomes
- Pediatric health and respiratory diseases
- Medical and Biological Ozone Research
- Pathogenesis and Treatment of Hiccups
Russian Medical Academy of Continuous Professional Education
2018-2025
Institute for Postgraduate Medical Education
2018
Ministry of Health of the Russian Federation
2015-2018
Moscow State University of Medicine and Dentistry
2018
State Scientific Center of Coloproctology
2006-2015
.
.
Background : Epidemiological studies performed in different countries have identified a number of trends that allow to predict the problems related prevalence inflammatory bowel diseases (IBD), their severity and healthcare resources utilization. Aim To present comparative results two large epidemiological IBD Russian Federation (RF), i.e. ESCApe ESCApe-2. Materials methods Two multicenter cross-sectional cohort with similar design were at three-year interval. The had common aim: identify...
.
Aim of publication. To present recent RGA evidencebased medicine centered guidelines on diagnosis, rational pharmacotherapy and management irritable bowel syndrome (IBS). Summary. IBS - is a functional disorder manifested by recurrent abdominal pain that develops at least once per week characterized two the following signs: it related to movements, associated change in stool frequency and/ or shape. These symptoms should be patient for last 3 months overall duration observation six more....
To assess the long-term result of medical treatment in patients with a severe attack (SA) ulcerative colitis (UC).The course UC was analyzed 56 who were accessible by telephone contact and consecutively recruited for year after therapy SA UC. All stated to have according Truelove-Witts' criteria; they received intravenous glucocorticosteroids (GCS) (prednisolone 2 mg/kg) along anti-recurrence mesalasine (5-ASA) or azathioprine (AZA). Ten (17.9%) GCS-resistant given infliximab (INF) (5 mg/...
AIM: to establish the consensus on controversial issues of surgery for Сrohn’s disease by Delphi method. METHODS: a cross-sectional study was conducted 62 experts voted intramural and anonymous (31.03.23). 5 statements from current edition clinical guidelines were selected correction working group further voting [2]. Based practical experience literature data, 3 new created also. Statements that do not reach required level agreement (80% or more) will be subjected Round 2 RESULTS: all took...
Aim. To study the opinions of gastroenterologists about drugs affecting intestinal microflora.
 Materials and methods. A qualitative survey was conducted in focus groups to patterns prescribing that regulate microflora chronic gastrointestinal diseases. The included only outpatient who managed patients with irritable bowel syndrome, an uncomplicated diverticular disease clinical manifestations excessive bacterial growth small intestine for at least 3 years.
 Results. Physicians...
The article is devoted to the use of vedolizumab, an α4β7 integrin antagonist, in treatment inflammatory bowel diseases (ulcerative colitis and Crohn’s disease). It presents results clinical trials drug experience using vedolizumab actual practice. latest available information about drug’s safety profile provided. authors considered practical aspects therapy, such as determining indications for treatment, tactics loss response, need a combination with immunosuppressors, specific categories patients.